| Application no. and date | 16856274.2 (espacenet) (Federated) (European Patent Register), 20161014 | | Patent/reg. no. and date | DK/EP 3362065, 20240403 | | Publication date | 20180822 | | Priority no. and date | US 201562242267 P, 20151015, US 201562255253 P, 20151113 | | EP pub. no. and date |
EP 3362065 20180822 | | Effective date | | | Applicant/owner | Les Laboratoires Servier, 50 rue Carnot
92284 Suresnes Cedex, FR | | Applicant ref. no. | P84696DK01 | | Inventor | AGRESTA, Samuel, V., 24 Coolidge Road
Lexington, MA 02420, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/136 (2006.01) , A61K 31/4439 (2006.01) , A61K 31/444 (2006.01) , A61K 31/704 (2006.01) , A61K 31/7048 (2006.01) , A61K 31/7068 (2006.01) , A61K 45/06 (2006.01) , A61P 35/02 (2006.01) , C07H 19/06 (2006.01) | | Title | KOMBINATIONSBEHANDLING OMFATTENDE IVOSIDENIB, CYTARABIN OG DAUNORUBICIN ELLER IDARUBICIN TIL BEHANDLING AF AKUT MYELOID LEUKÆMI | | Int. application no. | US2016057036 | | Int. publication no. | WO2017066566 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
